- Company Directors - M
- Mitchell Daniel J
Insider Trading History of Mitchell Daniel J
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Mitchell Daniel J since 2005.
The trader's CIK number is 1113661.
At the time of the last reporting, Mitchell Daniel J was the Director of Arca Biopharma, Inc.. (stock ticker symbol ABIO).
Also see all insider trading activities at Arca Biopharma, Inc..
Note that in the past
MITCHELL DANIEL J also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Myogen Inc (MYOG) by Mitchell Daniel J
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2006 | MYOG | 5,000 | $166,483 | 0 | $0 | 0 | $0 |
| 2005 | MYOG | 11,000 | $76,016 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Arca Biopharma, Inc. (ABIO) by Mitchell Daniel J
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2017 | ABIO | 11,000 | $29,810 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Cardiovascular Systems Inc (RDYN) by Mitchell Daniel J
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2008 | RDYN | 71,955 | $47,907 | 0 | $0 | 0 | $0 |
| 2006 | RDYN | 18,901 | $188,571 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Globeimmune Inc (GBIM) by Mitchell Daniel J
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2016 | GBIM | 0 | $0 | 244,745 | $453,523 | 0 | $0 |
| 2014 | GBIM | 85,000 | $850,000 | 0 | $0 | 0 | $0 |
Insider trading activities at 4 companies by Mitchell Daniel J:
1. Myogen Inc (MYOG)
2. Arca Biopharma, Inc. (ABIO)
3. Cardiovascular Systems Inc (RDYN)
4. Globeimmune Inc (GBIM)
Table 1. Insider trading of Myogen Inc (MYOG) by Mitchell Daniel J
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2006-05-23 | MYOG | Buy | 2,000 | 29.56 | 59,120 |
| 2006-03-13 | MYOG | Buy | 3,000 | 35.79 | 107,363 |
| 2005-07-06 | MYOG | Buy | 5,000 | 7.15 | 35,750 |
| 2005-06-29 | MYOG | Buy | 6,000 | 6.71 | 40,266 |
Table 2. Insider trading of Arca Biopharma, Inc. (ABIO) by Mitchell Daniel J
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2017-05-02 | ABIO | Buy | 11,000 | 2.71 | 29,810 |
Table 3. Insider trading of Cardiovascular Systems Inc (RDYN) by Mitchell Daniel J
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2008-12-12 | RDYN | Buy | 10,000 | .74 | 7,450 |
| 2008-12-11 | RDYN | Buy | 7,500 | .66 | 4,950 |
| 2008-12-10 | RDYN | Buy | 11,760 | .70 | 8,290 |
| 2008-12-02 | RDYN | Buy | 22,695 | .61 | 13,957 |
| 2008-12-03 | RDYN | Buy | 20,000 | .66 | 13,260 |
| 2006-09-14 | RDYN | Buy | 560 | 9.97 | 5,583 |
| 2006-09-13 | RDYN | Buy | 400 | 9.93 | 3,972 |
| 2006-09-12 | RDYN | Buy | 500 | 10.30 | 5,150 |
| 2006-09-11 | RDYN | Buy | 1,000 | 10.00 | 10,000 |
| 2006-09-11 | RDYN | Buy | 1,000 | 10.00 | 10,000 |
| 2006-09-08 | RDYN | Buy | 1,911 | 9.75 | 18,632 |
| 2006-09-07 | RDYN | Buy | 2,300 | 9.66 | 22,218 |
| 2006-08-10 | RDYN | Buy | 6,037 | 10.06 | 60,732 |
| 2006-08-11 | RDYN | Buy | 1,230 | 10.05 | 12,361 |
| 2006-08-11 | RDYN | Buy | 1,230 | 10.05 | 12,361 |
| 2006-08-09 | RDYN | Buy | 2,733 | 10.09 | 27,562 |
Table 4. Insider trading of Globeimmune Inc (GBIM) by Mitchell Daniel J
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2016-03-16 | GBIM | Sale | 8,974 | 1.85 | 16,610 |
| 2016-03-17 | GBIM | Sale | 12,626 | 1.52 | 19,191 |
| 2016-03-15 | GBIM | Sale | 51,476 | 2.17 | 111,599 |
| 2016-03-11 | GBIM | Sale | 78,793 | 2.31 | 182,405 |
| 2016-03-09 | GBIM | Sale | 5,800 | 1.21 | 7,012 |
| 2016-03-08 | GBIM | Sale | 5,900 | 1.14 | 6,725 |
| 2016-03-10 | GBIM | Sale | 4,700 | 1.16 | 5,447 |
| 2016-03-04 | GBIM | Sale | 6,520 | 1.02 | 6,637 |
| 2016-03-03 | GBIM | Sale | 1,700 | 1.12 | 1,902 |
| 2016-03-07 | GBIM | Sale | 3,700 | 1.07 | 3,970 |
| 2016-02-26 | GBIM | Sale | 6,701 | .95 | 6,345 |
| 2016-02-25 | GBIM | Sale | 2,059 | 1.06 | 2,188 |
| 2016-02-24 | GBIM | Sale | 3,741 | 1.17 | 4,369 |
| 2016-02-19 | GBIM | Sale | 14,358 | 1.43 | 20,560 |
| 2016-02-22 | GBIM | Sale | 5,800 | 1.43 | 8,270 |
| 2016-02-23 | GBIM | Sale | 2,700 | 1.36 | 3,672 |
| 2016-02-18 | GBIM | Sale | 11,922 | 1.42 | 16,905 |
| 2016-02-16 | GBIM | Sale | 2,041 | 1.50 | 3,053 |
| 2016-02-17 | GBIM | Sale | 7,934 | 1.48 | 11,702 |
| 2016-02-08 | GBIM | Sale | 3,200 | 2.01 | 6,425 |
| 2016-02-09 | GBIM | Sale | 2,800 | 1.99 | 5,574 |
| 2016-02-05 | GBIM | Sale | 1,300 | 2.28 | 2,962 |
| 2014-07-08 | GBIM | Buy | 85,000 | 10.00 | 850,000 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Mitchell Daniel J
(Director of Arca Biopharma, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.